Table 1 Micro-RNAs as Diagnostic or Prognostic markers in FFPE Samples

Head and Neck Squamous cell carcinoma

miR-16, -20a, -21, -106b, -142-3p, -155, -423, let-7i (up);

miR-10a, -125b, -375 (down)

miR-451 (up)

[47]

Breast cancer

miR-21(up); let-7a, miR-145, -205 (down)

[70]

miR-21 (up)

[71]

miR-21, -155, -191, -196a (up); miR-125b, -221 (down)

[44]

Lung cancer

miR-21, -205

[72]

miR-16 (up)

[73]

Gastric cancer

miR-106a (up)

[74]

miR-31 (down)

[75]

miR-10b, -21, -223, -338 (up);

miR-30a-5p,

-126, let-7a (down)

[37]

Pancreatic cancer

miR-452, -105, -127, -518a-2, -187, -30a-3p (up)

miR-196a-2 (up)

[76]

miR-21, -155 (up)

[77]

miR-21, -221, -222, let-7a (up)

[78]

miR-200c (down)

[79]

Cervical cancer

miR-9, -200a

[39]

Ovarian cancer

miR-223 (up); miR-9 (down)

[80]

miR-200a, -200b, -429 (down)

[81]

miR-23a, -27a (up)

[82]

miR-29b (up)

[83]

Prostate cancer

miR-125b (up)

[84]

miR-15a, -16 (down)

[85]

miR-184 (up); miR-146a (down)

miR-184 (up)

[86]

miR-203 (down)

[87]

miR-34c (down)

miR-34c (down)

[88]

miR-221 (down)

[89]